SCHEMBL19994530

SCHEMBL19994530

Cc1ccc(CCC2CCN(C(=O)O)CC2)cc1

nearest known ligand 0.56

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.56
FAAH O00519 2/20 0.48
GRIN2B Q13224 2/20 0.47
KDM4E B2RXH2 1/20 0.45
LMNA P02545 1/20 0.45
MAPT P10636 1/20 0.45
ALDH1A1 P00352 1/20 0.44
GRIN2D O15399 1/20 0.43
GRIN3B O60391 1/20 0.43
GRIN1 Q05586 1/20 0.43
GRIN2A Q12879 1/20 0.43
GRIN2C Q14957 1/20 0.43
GRIN3A Q8TCU5 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4242914 0.87 MAOB (0.54) MAOBFAAHGRIN2BGRIN2DGRIN3B
SCHEMBL28098494 0.86 MAOB (0.57) MAOBFAAHGRIN2BGRIN2DGRIN3B
SCHEMBL8670678 0.86 MAOA (0.55) MAOBGRIN2BGRIN2DGRIN3BGRIN1
SCHEMBL19994655 0.85 FAAH (0.45) MAOBFAAHGRIN2BALDH1A1GRIN2D
SCHEMBL1581379 0.85 FAAH (0.60) MAOBFAAHMAPT
SCHEMBL15954401 0.85 MAOB (0.47) MAOBFAAHGRIN2BGRIN2DGRIN3B
SCHEMBL19994566 0.85 MAOB (0.56) MAOBFAAH
SCHEMBL19026472 0.85 FAAH (0.45) MAOBFAAHGRIN2BGRIN2DGRIN3B
SCHEMBL5169485 0.84 FAAH (0.63) FAAHKDM4ELMNAMAPT
SCHEMBL19994570 0.84 MAOB (0.59) MAOBFAAHGRIN2BALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3426634-A1 DISUBTITUTED AZETIDINES, PYRROLIDINES, PIPERIDINES AND AZEPANES AS INHIBITORS OF MONOAMINE OXIDASE B FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES University of Ljubljana (SI) 2019-01-16 EP disclosed
WO-2018055096-A1 DISUBTITUTED AZETIDINES, PYRROLIDINES, PIPERIDINES AND AZEPANES AS INHIBITORS OF MONOAMINE OXIDASE B FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES UNIVERSITY OF LJUBLJANA (SI) 2018-03-29 WO disclosed